Gliomas and the microenvironment

Recently, the term “microenvironment” has been introduced to indicate all the cell types and molecular signaling that in tumors regulates transformation, growth, invasion, therapeutic resistance and defense from host immunity. In malignant gliomas, i.e., glioblastoma, the most malignant of gliomas, the cell component is represented by microglia/macrophages, reactive astrocytes, fibroblasts, pericytes, immune cells, beside tumor cells, whereas the molecular signaling can be either intrinsic or extrinsic. The microenvironment maximum expression points are the so-called “niches,” perivascular or peri-necrotic, where progression and regression mechanisms take place, mainly cell proliferation, angiogenesis for building new vessels, invasion and resistance to radio- and chemo-therapy. The niches are also the sites where tumor stem cells – the product of a tumor transformation of the primitive cells or normal neural stem cells, which during embryogenesis give origin to the entire nervous system – reside or are generated.

Fig. 1. Nestin-positive cells around a small vessel. X  400.

Fig. 1. Nestin-positive cells around a small vessel. X 400.

The histologic aspect of niches is not completely known, even though the occurrence in them of tumor stem cells is mandatory for their recognition. Not every peri-vascular distribution of cells is a niche. The simplest form is represented by cells positive for Nestin and CD133 – stemness or undifferentiation antigens that characterize stem cells and tumor stem cells – distributed around capillaries. Niches are, therefore, recognizable for the occurrence of stem cells or tumor stem cells expressing undifferentiation antigens. The most important molecular interchange is that between vessel endothelial cells and tumor stem cells: the former through Notch maintain the stemness status of stem cells and the latter stimulate endothelial cell proliferation for angiogenesis through VEGF and SD1.

Peri-necrotic niches are conceived as circumscribed necroses surrounded by tumor stem cells, evidenced as said before, generated through hypoxia or oxygen deprivation and its factor HIF.1/2. However, other interpretations are available. Hyperproliferating areas of the tumor occur near a central necrosis and within them an imbalance between the high proliferation capacity of tumor cells and the low one of endothelial cells occurs as to cause an ischemia, i.e. an insufficient blood supply to the hyperproliferating areas and then a circumscribed necrosis. Since hyperproliferating areas are formed mainly by tumor stem cells or their progenitors, the peri-necrotic position of tumor stem cells in the niche could be due to their sparing outside the necrosis.

Fig. 2. SOX2-positive cells crowding around a circumscribed necrosis. X 400.

Fig. 2. SOX2-positive cells crowding around a circumscribed necrosis. X 400.

The microenvironment action is realized through either intrinsic pathways such as those of Wnt/β-catenin, BMI1, Nanog, Oct4 and c-Myc and extrinsic pathways such as those of EGFR, PTEN, PI3K/AKT, Bmp and LOH that regulate proliferation, angiogenesis and invasion and are in a strict relationship with the generation or maintenance of tumor stem cells. The origin of tumor stem cells is generally conceived to be realized either from the tumor transformation of normal neural stem cells or from dedifferentiation of adult normal astrocytes or tumor astrocytic cells or from oligodendroglial NG2+ precursors. However, many believe that the tumor stem cells do not represent a special cell type, but rather a functional status that can be acquired or lost. There would be a transition from tumor cells to tumor stem cells and viceversa, regulated by the microenvironment; one could speak of a conversion among cell statuses operated by it.

Davide Schiffer
Research Center, Policlinico di Monza Foundation, Vercelli, Italy

 

Publication

The Microenvironment in Gliomas: Phenotypic Expressions.
Schiffer D, Annovazzi L, Mazzucco M, Mellai M
Cancers (Basel). 2015 Dec

FacebooktwitterlinkedinmailFacebooktwitterlinkedinmail

Leave a Reply